Antithrombotic therapy usage within 12 months of initial stroke
| Antithrombotic therapy | Total (n=12 415) | Without GIB (n=12 093) | With GIB (n=322) | P values |
| At discharge (n) | 8517 | 8433 | 84 | |
| Usage at 3 months (%) | 73.55 | 73.67 | 60.71 | 0.007 |
| Usage at 6 months (%) | 67.49 | 67.65 | 51.19 | 0.001 |
| Usage at 12 months (%) | 43.85 | 44.04 | 25.00 | <0.001 |
GIB, gastrointestinal bleeding.